SillaJen IPO Part 2 - Growth Potential & Appropriate Valuation Level
* In Part 2 (as below), I summarized the growth potential and appropriate valuation level of SillaJen.Apparently, not many people are doubtful...
254 Views
Celltrion Healthcare IPO, Unlikely to Have Owner Premium Factor
Celltrion Healthcare, Celltrion (068270)’s overseas sales and marketing unit, decided to be listed in KOSDAQ (instead of Korea’s main bourse) as...
323 Views
SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing
SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...
3.4k Views
Alpha Generation Through Share Buybacks in Korea: June & July 2023
We provide a list of 38 stocks in the Korean stock market that have announced share buyback programs in June and July 2023.
340 Views
Alpha Generation Through Share Buybacks in Korea: August & September 2023
In this insight, we discuss the alpha generation through companies that announced share buybacks in Korea in August and September 2023.
596 Views